Larger gene panels are the predominant NGS testing strategy in EU5 Larger gene panels are the predominant NGS testing strategy… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx) | Europe | IVD Gateway | LabPRO Plus | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx)
Europe: precision medicine and access to NGS cancer biomarker testing Precision medicine and access to NGS cancer biomarker… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx) | Europe | IVD Gateway | LabPRO Plus | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx)
Proportion of cancer biomarker testing done with NGS expected to double in 2022 compared to 2019 Proportion of cancer biomarker testing done with NGS… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Tissue Diagnostics (TDx) | Europe | IVD Gateway | LabPRO Plus | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx)
Insights into Europe’s covid-19 testing and technology use 2021-2022: PCR v serology v antigen Europe is shifting its covid-19-approach from pandemic to… Centralised Diagnostics (CEDx) | Covid-19 testing | In-vitro diagnostics | Molecular Diagnostics (MDx) | Europe | IVD Gateway | Molecular Diagnostics (MDx)
Watch on-demand: Will Covid-19 Accelerate the Next Wave of Adoption of Next-Generation Sequencing (NGS) in Healthcare? Now, sequencing looks set to become even more integral in… Covid-19 testing | In-vitro diagnostics | Next Generation Sequencing (NGS) | Uncategorised | Global | IVD Gateway | Next Generation Sequencing (NGS)
The fastest-growing areas for LATAM’s next-generation sequencing market The next-generation sequencing (NGS) market is expected to… In-vitro diagnostics | Next Generation Sequencing (NGS) | Americas | IVD Gateway | Next Generation Sequencing (NGS)
The fastest-growing areas for APAC’s next-generation sequencing market The next-generation sequencing (NGS) market is expected to… In-vitro diagnostics | Next Generation Sequencing (NGS) | Asia | IVD Gateway | Next Generation Sequencing (NGS)
2022 healthcare megatrends shaping IVD 2022 healthcare megatrends shaping IVD… In-vitro diagnostics | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT) | Asia | Europe | Middle East & Africa | IVD Gateway | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT)
Rapid antigen tests to erode PCR-based molecular covid test market in APAC Emergent covid-19 screening technologies coupled with… Covid-19 testing | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Molecular diagnostics instrument sales in Asia-Pacific set to normalise as vaccination rates rise Molecular diagnostics (MDX) instrument sales in Asia-Pacific… In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Covid-19: Molecular testing capacity expands in Asia-Pacific Molecular diagnostics (MDx) testing capacities and… Covid-19 testing | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Tissue-based companion diagnostics market to grow for the most common cancers in China Companion diagnostics (CDx) use is growing as the cancer… In-vitro diagnostics | Tissue Diagnostics (TDx) | Asia | IVD Gateway | Tissue Diagnostics (TDx)